The Supreme Court rejected an appeal by Pfizer that sought to thwart a securities lawsuit alleging the drugmaker misrepresented the safety profile of the blockbuster pain drug Celebrex.
WSJ.com: What's News US, Wall Street Journal
Mon, 05/03/2010 - 7:44am